Search
for
Sort by
Research 31–60 of 1000+
- 170 Forecasting Phase 3 Dose-Response for Abrocitinib, an Oral Janus Kinase 1 Selective Inhibitor, Using Investigator’s Global Assessment and Eczema Area and Severity Index
- Synthesis and in vitro study of 17β-[N-ureylene-N,N′-disubstituted]-4-methyl-4-aza-5α-androstan-3-ones as selective inhibitors of type I 5α-reductase
- 265 Modulation of disease-central cytokine pathways with TAK-279, a highly selective oral tyrosine kinase 2 (TYK2) inhibitor, defines clinical response in patients with psoriasis
- Selective inhibition of JAK3 signaling is sufficient to reverse alopecia areata
- Efficacy and safety of janus kinase inhibitors in the treatment of alopecia areata in children
- Selective blockade of γc pathway ameliorates alopecia areata in a humanized murine model
- 695 Selectively targeting JAK1 or JAK3 pathway is sufficient to reverse alopecia areata
- Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men
- High-performance liquid chromatographic determination of the enantiomers of the benzoquinolinone LY 191704, a human type 1 5α-reductase inhibitor, in plasma
- Selection of Anti-Depressants in Geriatric Dermatoses- A Questionnaire Study of Dermatologists in Western Rajasthan, India
- Alopecia: A Less Known but Devastating Side Effect of Serotonin Reuptake Inhibitors
- 876 Manipulation of stem cell divisional behavior: Selectively promoting asymmetric and symmetric keratinocyte divisions in vitro
- 5α-Reduced glucocorticoids: a story of natural selection
- Comprehensive Safety Exposure‐Response Analysis to Support Ritlecitinib Dose Selection
- 27 Preclinical ex vivo and in vivo evidence supporting selective inhibition of tyrosine kinase 2-dependent, IL-12-mediated signaling as a novel pharmacological strategy for alopecia areata management
- A Thallium-Based Screening Procedure to Identify Molecules That Modulate the Activity of Ca2+-Activated Monovalent Cation-Selective Channels
- Ruxolitinib reverses alopecia areata via a triple mechanism: JAK-STAT inhibition, localized oxidative stress attenuation and selective apoptosis modulation
- Expression and Activity Assay of Human Steroid 5 Alpha-Reductase Type II in CHO Cells
- Pegylated-interferon-α<sub>2a</sub>in clinical practice: how to manage patients suffering from side effects
- Evaluation of risk of SSRI-associated impotence and low libido in men exposed to finasteride
- Androgen receptor modulators: a review of recent patents and reports (2012-2018)
- Novel Uses for the Anabolic Androgenic Steroids Nandrolone and Oxandrolone in the Management of Male Health
- Emerging drugs for hypogonadism
- Androgen Receptor Ligands: Agonists and Antagonists
- A clinical case of familial alopecia areata in combination with immune pathology
- Psychotropic Treatment of Psychodermatologic Disorders
- Intracrine and Myotrophic Roles of 5α-Reductase and Androgens
- Sudden improvement of alopecia universalis and psoriatic arthritis while receiving upadacitinib: a case-based review
- Chemoprävention des Prostatakarzinoms - Ein Plädoyer
- Slow progress in prostate cancer